Drug related problems and pharmacist interventions in a geriatric unit employing electronic prescribing

Abstract

A resident pharmacist detected various DRPs. Most PIs were accepted. DRPs related to the misuse of the CPOE system appeared potentially dangerous and need particular attention by healthcare professionals. The description of the DRPs is an essential step for implementation of targeted clinical pharmacy services in order to optimize pharmacists' job time.

Cross‐sectional investigation of drug‐related problems among adults in a medical center outpatient clinic: application of virtual medicine records in the cloud

“…The prevalence of DRP classification in these results (Table ) is similar to that of previous studies, indicating that unnecessary drug prescriptions often lead to DRPs in the elderly in Taiwan, similar to other countries. This is likely because the elderly often suffer from multiple simultaneous chronic diseases, and require visits to multiple departments, leading to multi‐drug therapies, potentially inappropriate duplication or combinations of drugs, and drug–drug interactions.…”

“…Numerous studies have noted that elderly patients are at increased risk of DRPs during the medication use process, which can lead to adverse clinical outcomes . This may be related to polypharmacy, pharmacokinetics/pharmacodynamics, and cognitive and functional alterations among elderly people .…”

“…3,4 Many studies have found that chronic diseases such as diabetes, benign prostatic hyperplasia, cardiovascular disease, and even polypharmacy are susceptible to DRPs. [5][6][7][8] Among the elderly in particular, patients with a variety of chronic diseases who attend various clinics are at risk for polypharmacy, and subsequent DRPs, [9][10][11][12][13][14][15] the main causes being persistence of symptoms, multiple chronic diseases, inability to understand doctors' explanations, and distrust of diagnosis and treatment. 1,[16][17][18] Clinical pharmacists involved in multidisciplinary teams can effectively solve and prevent DRPs in elderly patients with multiple chronic diseases.…”

The French Society of Clinical Pharmacy ACT-IP© project: Ten years onward, results and prospects

“…Full agreement for the growth and further use of these instruments within 3 to 5 years Several publications strongly encourage us to go beyond the simple drug prescriptions analysis to a wider integration of the pharmacist in the therapeutics management of the hospitalized or ambulatory patient [41,43,45,54,[80][81][82][83][84][85][86]. In order to respond to the transition to a complete offer of pharmaceutical services including ''medication reconciliation, detection and description of adverse reactions, pharmaceutical interventions, medication plan and community-hospital relations'', it is still necessary to identify barriers with such a transition and to lift the following barriers evoked over the years: drug prescriptions not transmitted to the pharmacist, then priority given to the robotization and the computerization that require an important processing time.…”

Mise à disposition de l’outil de codification des interventions pharmaceutiques de la Société française de pharmacie clinique : bilan à 10ans et perspectives

“…Lever les obstacles pour que d'ici 3 à 5 ans la révolution culturelle actuellement en cours trouve sa pleine application Des confrères nous donnent des pistes pour passer de l'analyse d'ordonnances à une intégration plus large du pharmacien dans la prise en charge de la thérapeutique médicamenteuse du patient, qu'il soit hospitalisé ou ambulatoire [41,43,45,54,[80][81][82][83][84][85][86]. Il s'agit maintenant d'assurer la transition de « l'analyse de prescription » à un service pharmaceutique global assemblant « conciliation médica-menteuse, détection et signalement des effets indésirables, interventions pharmaceutiques, plan de soin médicamen-teux et communication ville-hôpital ».…”